Search





Search





Markets
/
Stocks
/
vvos
/

Vivos Therapeutics Inc

VVOS

Add to Watchlist

0.410USD

+0.004+1.03%

Close 07-31 16:00（ET）Quotes delayed by 15 min

3.81MMarket Cap

LossP/E TTM

Vivos Therapeutics Inc

0.410

+0.004+1.03%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

VVOS Cash Flow Statement

You can access the annual and quarterly cash flow statements of Vivos Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-58.32%-6.01M

-29.66%-3.81M

0.62%-4.16M

-14.63%-3.49M

-50.87%-3.80M

-6.99%-2.94M

-49.54%-4.19M

-6.61%-3.05M

28.91%-2.52M

8.40%-2.75M

52.07%-2.80M

38.69%-2.86M

41.81%-3.54M

27.22%-3.00M

-43.95%-5.84M

-26.24%-4.66M

-57.53%-6.08M

-13.92%-4.12M

-549.70%-4.06M

---3.69M

---3.86M

-129.94%-3.62M

16.52%-624.64K

---1.57M

---748.22K

Net income from continuing operations

-100.60%-7.75M

-145.99%-6.95M

-106.30%-5.40M

-159.88%-5.01M

-2.68%-3.86M

33.62%-2.83M

-25.04%-2.62M

65.10%-1.93M

-120.96%-3.76M

30.05%-4.26M

61.48%-2.09M

20.93%-5.53M

68.05%-1.70M

17.64%-6.09M

0.35%-5.43M

-72.94%-6.99M

-56.83%-5.33M

-18.30%-7.39M

-200.76%-5.45M

---4.04M

---3.40M

-137.89%-6.25M

41.36%-1.81M

---2.63M

---3.09M

Operating gains losses

156.50%454.00K

206.94%442.00K

163.01%384.00K

111.03%306.00K

21.23%177.00K

-3.36%144.00K

-2.01%146.00K

-2.03%145.00K

-16.57%146.00K

-11.83%149.00K

-15.34%149.00K

-47.70%148.00K

326.83%175.00K

0.46%169.00K

-8.57%176.00K

45.30%283.00K

-76.90%41.00K

-5.13%168.23K

7.58%192.50K

--194.77K

--177.50K

-1.88%177.32K

-6.14%178.93K

--180.72K

--190.64K

Other non-cash items

--514.00K

-2100.00%-100.00K

----

-97.11%5.00K

103.82%6.00K

-86.34%25.00K

-99.92%6.00K

239.52%173.00K

-164.34%-157.00K

-50.41%183.00K

778.62%7.08M

-113.72%-124.00K

2615.72%244.00K

6382.99%369.00K

-524.39%-1.04M

-74.12%903.81K

-2403.80%-9.70K

---5.87K

--245.77K

4916.95%3.49M

42000.00%421.00

--69.61K

--1.00

Change in working capital

213.15%482.00K

963.01%2.75M

142.86%799.00K

155.87%871.00K

-153.12%-426.00K

-135.21%-319.00K

-361.43%-1.86M

-254.05%-1.56M

244.21%802.00K

-60.07%906.00K

160.53%713.00K

3.48%1.01M

165.08%233.00K

30.74%2.27M

-1280.47%-1.18M

300.37%978.00K

72.86%-358.00K

193.06%1.74M

-82.81%99.79K

---488.08K

---1.32M

-705.04%-1.86M

-61.86%580.51K

--308.23K

--1.52M

-Change in receivables

34.72%-188.00K

2204.17%553.00K

-749.15%-501.00K

-85.50%19.00K

11.11%-288.00K

-7.69%24.00K

-159.60%-59.00K

2283.33%131.00K

-338.24%-324.00K

-93.64%26.00K

233.78%99.00K

-102.86%-6.00K

-32.34%136.00K

-84.45%409.00K

80.13%-74.00K

111.69%210.00K

185.92%201.00K

632.18%2.63M

-6.51%-372.44K

---1.80M

---233.94K

-891.59%-494.23K

-181.59%-349.67K

---49.84K

--428.59K

-Change in prepaid expenses

-170.34%-166.00K

-41.22%-209.00K

260.49%130.00K

-74.68%-138.00K

67.38%236.00K

-196.73%-148.00K

-126.64%-81.00K

-128.94%-79.00K

38.24%141.00K

-77.06%153.00K

652.73%304.00K

40.72%273.00K

115.00%102.00K

2378.26%667.00K

-177.49%-55.00K

126.03%194.00K

-167.12%-680.00K

-80.84%26.91K

128.44%70.97K

---745.32K

---254.57K

341.27%140.49K

-363.24%-249.52K

--31.84K

---53.87K

-Change in other current assets

-2700.00%-26.00K

-131.15%-19.00K

-633.33%-16.00K

70.27%63.00K

-75.00%1.00K

6200.00%61.00K

50.00%3.00K

--37.00K

-94.94%4.00K

-200.00%-1.00K

300.00%2.00K

-100.00%0.00

2533.33%79.00K

100.19%1.00K

-105.28%-1.00K

13182.39%497.00K

104.88%3.00K

-7020.58%-516.67K

473.40%18.95K

---3.80K

---61.48K

-624.88%-7.26K

-184.58%-5.08K

---1.00K

--6.00K

-Change in other current liabilities

40200.00%401.00K

-16.47%-580.00K

162.84%411.00K

117.22%139.00K

-100.19%-1.00K

-107.50%-498.00K

-610.94%-654.00K

-186.50%-807.00K

407.02%525.00K

-170.80%-240.00K

-40.47%128.00K

99.36%933.00K

28.75%-171.00K

135.85%339.00K

151.62%215.00K

-67.91%468.00K

-174.19%-240.00K

-244.59%-945.51K

-333.75%-416.50K

--1.46M

---87.53K

-233.38%-274.39K

-71.53%178.18K

--205.72K

--625.94K

Cash from non-recurring investing activities

Cash from operating activities

-58.32%-6.01M

-29.66%-3.81M

0.62%-4.16M

-14.63%-3.49M

-50.87%-3.80M

-6.99%-2.94M

-49.54%-4.19M

-6.61%-3.05M

28.91%-2.52M

8.40%-2.75M

52.07%-2.80M

38.69%-2.86M

41.81%-3.54M

27.22%-3.00M

-43.95%-5.84M

-26.24%-4.66M

-57.53%-6.08M

-13.92%-4.12M

-549.70%-4.06M

---3.69M

---3.86M

-129.94%-3.62M

16.52%-624.64K

---1.57M

---748.22K

Investing cash flow

Net cash from continuing investing activities

-85.25%18.00K

827.88%1.53M

-143.23%-83.00K

1185.00%771.00K

-19.21%122.00K

0.00%165.00K

24.68%192.00K

-75.51%60.00K

-36.82%151.00K

-17.50%165.00K

54.00%154.00K

-51.39%245.00K

99.17%239.00K

-47.73%200.00K

-77.30%100.00K

-61.56%504.00K

-54.15%120.00K

301.77%382.65K

3569.30%440.46K

--1.31M

--261.70K

8.93%95.24K

-50.68%12.00K

--87.44K

--24.34K

Capital expenditures

-85.25%18.00K

827.88%1.53M

----

1185.00%771.00K

-19.21%122.00K

0.00%165.00K

24.68%192.00K

-75.51%60.00K

-36.82%151.00K

-17.50%165.00K

54.00%154.00K

-51.39%245.00K

99.17%239.00K

-47.73%200.00K

-77.30%100.00K

-61.56%504.00K

-54.15%120.00K

301.77%382.65K

3569.30%440.46K

--1.31M

--261.70K

8.93%95.24K

-50.68%12.00K

--87.44K

--24.34K

Net cash flow from disposal of fixed assets

-85.25%18.00K

827.88%1.53M

-143.23%-83.00K

1185.00%771.00K

-19.21%122.00K

0.00%165.00K

24.68%192.00K

-75.51%60.00K

-36.82%151.00K

-17.50%165.00K

54.00%154.00K

-51.39%245.00K

99.17%239.00K

-47.73%200.00K

-77.30%100.00K

-61.56%504.00K

-54.15%120.00K

301.77%382.65K

3569.30%440.46K

--1.31M

--261.70K

8.93%95.24K

-50.68%12.00K

--87.44K

--24.34K

Net cash flow from business transactions

----

---50.00K

--0.00

---5.13M

----

--0.00

----

--0.00

---225.00K

----

--250.00K

----

Net cash flow from other investing activities

--0.00

---50.00K

--0.00

----

--0.00

----

--0.00

---50.00K

-100.00%0.00

----

--301.00

--8.49K

--4.21K

----

--11.82K

----

Cash from non-current investing activities

Net cash flow from investing activities

85.25%-18.00K

-858.18%-1.58M

143.23%83.00K

-9743.33%-5.91M

19.21%-122.00K

0.00%-165.00K

-24.68%-192.00K

75.51%-60.00K

47.75%-151.00K

17.50%-165.00K

-54.00%-154.00K

51.39%-245.00K

-140.83%-289.00K

47.69%-200.00K

76.85%-100.00K

67.10%-504.00K

54.15%-120.00K

-301.45%-382.35K

-3498.57%-431.97K

---1.53M

---261.70K

-154.62%-95.24K

50.68%-12.00K

--174.39K

---24.34K

Financing cash flow

Cash flow from continuous financing activities

--6.11M

41.94%4.33M

-27.04%2.76M

54.86%11.46M

-100.00%0.00

-14.41%3.05M

--3.79M

--7.40M

-50.58%3.63M

--3.57M

--0.00

--7.36M

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%-434.00

-166.18%-1.17M

--25.37M

---25.00K

2620.42%20.37M

7.73%1.77M

--748.75K

--1.65M

Net cash flow from debt Issuance/repayment

--980.00K

--1.53M

---531.00K

--9.64M

----

--0.00

100.00%0.00

--0.00

---25.00K

-109.75%-75.00K

-100.00%0.00

--769.00K

--1.77M

Net cash flow from common stock issuance/repurchase

--342.00K

-19.97%2.80M

-43.48%2.43M

--347.00K

----

--3.50M

--4.30M

----

--0.00

-100.00%0.00

----

-100.00%0.00

--330.00K

--27.60M

----

--22.29M

--0.00

----

--0.00

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

100.00%0.00

-182.28%-1.50M

----

---1.65M

3745.97%1.82M

--0.00

---50.00K

Proceeds from issuance of warrants

--5.27M

--0.00

--866.00K

-69.23%2.31M

----

-100.00%0.00

--0.00

--7.50M

-50.74%3.94M

--4.00M

--0.00

--8.00M

----

Net cash flow from other financing activities

---487.00K

100.00%0.00

-737.00%-837.00K

----

-3.24%-446.00K

---509.00K

---100.00K

52.56%-306.00K

---432.00K

--0.00

---645.00K

100.00%0.00

----

99.78%-434.00

92.98%-3.50K

---2.23M

----

-864.81%-195.38K

27.78%-49.83K

---20.25K

---69.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

--6.11M

41.94%4.33M

-27.04%2.76M

54.86%11.46M

-100.00%0.00

-14.41%3.05M

--3.79M

--7.40M

-50.58%3.63M

--3.57M

--0.00

--7.36M

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%-434.00

-166.18%-1.17M

--25.37M

---25.00K

2620.42%20.37M

7.73%1.77M

--748.75K

--1.65M

Net cash flow

Beginning cash balance

-67.59%2.03M

-51.09%3.09M

-36.23%4.40M

-10.30%2.34M

281.01%6.26M

538.77%6.31M

75.11%6.90M

-62.94%2.61M

-53.31%1.64M

-85.30%988.00K

-68.87%3.94M

-60.48%7.05M

-85.36%3.52M

-76.45%6.72M

-62.98%12.66M

26.82%17.83M

31.99%24.03M

1740.81%28.53M

8168.05%34.20M

--14.06M

--18.21M

38.43%1.55M

67.89%413.62K

--1.12M

--246.36K

Current period cash flow changes

102.07%81.00K

-1974.51%-1.06M

-122.13%-1.31M

-52.00%2.06M

-504.75%-3.92M

-107.79%-51.00K

79.96%-592.00K

238.27%4.29M

-72.55%968.00K

120.47%655.00K

50.29%-2.95M

39.93%-3.10M

156.87%3.53M

28.97%-3.20M

-4.91%-5.94M

-125.66%-5.17M

-49.53%-6.20M

-127.05%-4.50M

-598.35%-5.66M

--20.14M

---4.15M

2660.61%16.66M

30.12%1.14M

---650.45K

--873.44K

Ending cash balance

-9.91%2.11M

-67.59%2.03M

-51.09%3.09M

-36.23%4.40M

-10.30%2.34M

281.01%6.26M

538.77%6.31M

75.11%6.90M

-62.94%2.61M

-53.31%1.64M

-85.30%988.00K

-68.87%3.94M

-60.48%7.05M

-85.36%3.52M

-76.45%6.72M

-62.98%12.66M

26.82%17.83M

31.99%24.03M

1740.78%28.53M

--34.20M

--14.06M

3778.89%18.21M

38.43%1.55M

--469.35K

--1.12M

Free cash flow

-53.85%-6.03M

-72.08%-5.34M

4.98%-4.16M

-37.23%-4.26M

-46.91%-3.92M

-6.59%-3.10M

-48.24%-4.38M

-0.13%-3.11M

29.41%-2.67M

8.97%-2.91M

50.29%-2.95M

39.93%-3.10M

39.08%-3.78M

28.96%-3.20M

-32.08%-5.94M

-3.24%-5.17M

-50.44%-6.20M

-21.30%-4.50M

-606.64%-4.50M

---5.00M

---4.12M

-123.57%-3.71M

17.59%-636.64K

---1.66M

---772.56K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Vivos Therapeutics Inc Generate?



Vivos Therapeutics Inc generated -15.26M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Vivos Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Vivos Therapeutics Inc's operating cash flow increased by -20.27% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Vivos Therapeutics Inc Spend on Capital Expenditures?



Vivos Therapeutics Inc spent 2.34M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Vivos Therapeutics Inc's Financing Cash Flow Changed?



Vivos Therapeutics Inc used 18.56M in financing activities in the latest quarter.

What is free cash flow and why does it matter for VVOS?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Vivos Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -17.60M reflecting a -32.77% change from the previous year.